Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,414 | -27,077 | -14,919 | -10,235 | -26,433 |
| Depreciation Amortization | 273 | 256 | 240 | 141 | 613 |
| Accounts payable and accrued liabilities | -1,234 | -1,480 | 760 | -1,242 | -512 |
| Other Working Capital | -4,104 | -4,238 | -2,547 | -1,303 | -150 |
| Other Operating Activity | -15,855 | 4,613 | 1,412 | 2,359 | -29,474 |
| Operating Cash Flow | $-38,334 | $-27,926 | $-15,054 | $-10,280 | $-55,956 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -49,854 | 22,208 | 17,155 | 5,102 | 54,754 |
| PPE Investments | N/A | N/A | N/A | N/A | -71 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -90 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -89 |
| Investing Cash Flow | $-49,854 | $22,208 | $17,155 | $5,102 | $54,594 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 91 | 28 | 13 | 13 | 622 |
| Other Financing Activity | 75,116 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $75,207 | $28 | $13 | $13 | $622 |
| Exchange Rate Effect | -167 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 28,232 | 28,232 | 28,232 | 28,232 | 28,972 |
| End Cash Position | 15,084 | 22,542 | 30,346 | 23,067 | 28,232 |
| Net Cash Flow | $-13,148 | $-5,690 | $2,114 | $-5,165 | $-740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,334 | -27,926 | -15,054 | -10,280 | -55,956 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -71 |
| Free Cash Flow | -38,334 | -27,926 | -15,054 | -10,280 | -56,027 |